Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H32O4 |
| Molecular Weight | 324.455 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCCCCCCCOC1=CC=C(O1)C(O)=O
InChI
InChIKey=CZRCFAOMWRAFIC-UHFFFAOYSA-N
InChI=1S/C19H32O4/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-22-18-15-14-17(23-18)19(20)21/h14-15H,2-13,16H2,1H3,(H,20,21)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| From pathogenesis of acne vulgaris to anti-acne agents. | 2019-07 |
|
| Oily Skin: A review of Treatment Options. | 2017-08 |
|
| Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris. | 2017-07 |
|
| Anti-acne drugs in phase 1 and 2 clinical trials. | 2017-07 |
|
| Inhibition of Sebum Production with the Acetyl Coenzyme A Carboxylase Inhibitor Olumacostat Glasaretil. | 2017-07 |
|
| Olumacostat glasaretil, a novel topical sebum inhibitor, in the treatment of acne vulgaris: A phase IIa, multicenter, randomized, vehicle-controlled study. | 2017-01 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
77936
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY | |||
|
115175
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY | |||
|
54857-86-2
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY | |||
|
DTXSID60203338
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY | |||
|
100000174522
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY | |||
|
BI12FRY055
Created by
admin on Mon Mar 31 22:11:15 GMT 2025 , Edited by admin on Mon Mar 31 22:11:15 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PRODRUG (METABOLITE ACTIVE)